|
US1883113A
(en)
*
|
|
1932-10-18 |
|
new yoek |
|
US3906031A
(en)
*
|
1971-03-15 |
1975-09-16 |
Research Corp |
Novel 9-fluorenylmethoxycarbonyl compounds
|
|
US4394519A
(en)
*
|
1982-01-19 |
1983-07-19 |
Research Corporation |
Amino acid blocking agents
|
|
US4879398A
(en)
*
|
1987-12-31 |
1989-11-07 |
Monsanto Company |
Process for producing 2,6-disubstituted tyrosine
|
|
US5296608A
(en)
*
|
1988-04-25 |
1994-03-22 |
Hoffman-La Roche Inc. |
Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides
|
|
US5182263A
(en)
*
|
1988-04-25 |
1993-01-26 |
Hoffmann-La Roche Inc. |
Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
|
|
US5272268A
(en)
*
|
1990-06-28 |
1993-12-21 |
Shionogi & Co., Ltd. |
Dipeptide derivatives
|
|
US5679842A
(en)
*
|
1990-08-17 |
1997-10-21 |
Hoechst Aktiengesellschaft |
Process for the preparation of aminomethanephosphonic acid and aminomethylphosphinic acids
|
|
AU657498B2
(en)
*
|
1990-12-14 |
1995-03-16 |
Novartis Ag |
Biphenylyl compounds
|
|
DE4115468A1
(de)
*
|
1991-05-11 |
1992-11-12 |
Behringwerke Ag |
Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
|
|
US5200546A
(en)
*
|
1991-09-30 |
1993-04-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
|
|
US5587372A
(en)
*
|
1991-12-12 |
1996-12-24 |
Roussel Uclaf |
Cephalosporins
|
|
EP0655055B1
(en)
*
|
1992-08-13 |
2000-11-29 |
Warner-Lambert Company |
Tachykinin antagonists
|
|
TW399041B
(en)
*
|
1992-09-09 |
2000-07-21 |
Hoechst Ag |
Substituted cyclohexane derivatives, the preparation and the use for treating diseases
|
|
AU5136093A
(en)
|
1992-09-25 |
1994-04-26 |
Warner-Lambert Company |
Peptide antagonists of sh2 binding and therapeutic uses thereof
|
|
US5712395A
(en)
*
|
1992-11-13 |
1998-01-27 |
Yissum Research Development Corp. |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
|
|
US5792771A
(en)
*
|
1992-11-13 |
1998-08-11 |
Sugen, Inc. |
Quinazoline compounds and compositions thereof for the treatment of disease
|
|
US5981569A
(en)
*
|
1992-11-13 |
1999-11-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
|
|
EP0672059A1
(en)
*
|
1992-11-18 |
1995-09-20 |
The Du Pont Merck Pharmaceutical Company |
CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
|
|
GB9302331D0
(en)
*
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Process
|
|
PL179628B1
(pl)
*
|
1993-06-30 |
2000-10-31 |
Pharmacia Spa |
Peptydy b ed ace inhibitorami m itogenezy i m otogenezy, sp o só b ich wytwarzania, i zawierajacy je srodek farm aceutyczny PL PL PL PL PL PL
|
|
US5824862A
(en)
*
|
1993-08-19 |
1998-10-20 |
Japan Tobacco Inc. |
DNA encoding ATP-dependent fructose 6-phosphate 1-phosphotransferase originating from plant, recombinant vector containing the same and method for changing sugar content in plant cells under low temperature
|
|
US5491253A
(en)
*
|
1993-10-22 |
1996-02-13 |
Abbott Laboratories |
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
|
|
ES2157994T3
(es)
|
1993-10-25 |
2001-09-01 |
Parke Davis & Co |
Inhibidores tetra y pentapeptidos sustituidos de la proteina farnesiltransferasa.
|
|
US5576323A
(en)
*
|
1993-12-03 |
1996-11-19 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
|
WO1995024190A2
(en)
*
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
US6037134A
(en)
*
|
1994-03-07 |
2000-03-14 |
New York University Medical Center |
Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
|
|
US5580979A
(en)
*
|
1994-03-15 |
1996-12-03 |
Trustees Of Tufts University |
Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
|
|
US5849510A
(en)
*
|
1994-04-26 |
1998-12-15 |
Selectide Corporation |
Factor Xa inhibitors
|
|
US5707624A
(en)
*
|
1994-06-03 |
1998-01-13 |
The Regents Of The University Of Michigan |
Treatment of Kaposi's sarcoma by inhibition of scatter factor
|
|
US5786454A
(en)
*
|
1994-09-16 |
1998-07-28 |
Washington University School Of Medicine |
Modified SH2 domains
|
|
WO1996023813A1
(en)
*
|
1995-02-01 |
1996-08-08 |
Affymax Technologies N.V. |
Peptides and compounds that bind to sh2 domains
|
|
US5756817C1
(en)
*
|
1995-02-11 |
2001-04-17 |
Sk Corp |
O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
|
|
US5710129A
(en)
*
|
1995-02-23 |
1998-01-20 |
Ariad Pharmaceuticals, Inc. |
Inhibitors of SH2-mediated processes
|
|
US5688992A
(en)
*
|
1995-03-31 |
1997-11-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof
|
|
US5686292A
(en)
*
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US5646036A
(en)
*
|
1995-06-02 |
1997-07-08 |
Genentech, Inc. |
Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies
|
|
US5612370A
(en)
*
|
1995-06-07 |
1997-03-18 |
Bristol-Myers Squibb Company |
Phenylglycine and phenylalaninen amido benzopyran derivatives
|
|
WO1996040629A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
|
|
US5710173A
(en)
*
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
|
US5798374A
(en)
*
|
1995-06-07 |
1998-08-25 |
Sugen Inc. |
Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
|
|
US5880141A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
KR19990022369A
(ko)
*
|
1995-06-07 |
1999-03-25 |
스테판 이반스-프레크 |
어뎁터 단백질/티로신 카이나제 상호작용을 방해하는 조성물과그 방법
|
|
US5753687A
(en)
*
|
1995-06-19 |
1998-05-19 |
Ontogen Corporation |
Modulators of proteins with phosphotryrosine recognition units
|
|
US5965558A
(en)
*
|
1995-06-19 |
1999-10-12 |
Ontogen Corporation |
Modulators of proteins with phosphotyrosine recognition units
|
|
IT1282022B1
(it)
*
|
1995-07-06 |
1998-03-06 |
Mini Ricerca Scient Tecnolog |
Procedimento per la produzione di carbammati aromatici
|
|
GB9517060D0
(en)
|
1995-08-17 |
1995-10-25 |
Ciba Geigy Ag |
Acylated oligopeptide derivatives
|
|
WO1997012903A1
(en)
*
|
1995-10-04 |
1997-04-10 |
Warner-Lambert Company |
Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins
|
|
US5958957A
(en)
*
|
1996-04-19 |
1999-09-28 |
Novo Nordisk A/S |
Modulators of molecules with phosphotyrosine recognition units
|
|
US5948658A
(en)
*
|
1996-06-25 |
1999-09-07 |
The Trustees Of Columbia University In The City Of New York |
Anti-cocaine catalytic antibody
|
|
US5922697A
(en)
*
|
1996-10-02 |
1999-07-13 |
Warner-Lambert Company |
Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
|
|
SE9701718D0
(sv)
|
1997-05-07 |
1997-05-07 |
Astra Ab |
Analgesic peptidomimetic compounds
|
|
US6410585B1
(en)
|
1997-08-28 |
2002-06-25 |
Scott D. Larsen |
Inhibitors of protein tyrosine phosphatase
|
|
CA2298601A1
(en)
|
1997-08-28 |
1999-03-11 |
Pharmacia & Upjohn Company |
Inhibitors of protein tyrosine phosphatase
|
|
US6022696A
(en)
*
|
1998-04-02 |
2000-02-08 |
Washington State University Research Foundation |
Methods of identifying agonists or antagonists of angiotensin IV
|
|
US6228986B1
(en)
*
|
1998-04-13 |
2001-05-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Solid-phase synthesis of novel 14-membered macroycles for high throughput screening
|
|
US6307090B1
(en)
*
|
1999-01-22 |
2001-10-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Acylated oligopeptide derivatives having cell signal inhibiting activity
|
|
WO2000073326A2
(en)
|
1999-06-02 |
2000-12-07 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
|
